Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06860425 · ClinicalTrials.gov registry record · NA

Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity

A NA study of Cancer Patients and Mobile Applications, sponsored by Montefiore Medical Center.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06860425 is a NA study of Cancer Patients and Mobile Applications that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 50 participants, below the 238-participant average among 8 other Cancer Patients trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06860425, a NA study of Cancer Patients and Mobile Applications, is actively recruiting participants, sponsored by Montefiore Medical Center.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The overarching purpose of this study is to assess whether patients will use the app throughout treatment on a regular basis, as the ultimate goal is to provide an educational platform that can impact patient behaviors and understanding towards health.

Interventions

  • OTHER RestoreMe

Study Locations (1)

New York

  • Montefiore Einstein Comprehensive Cancer Center - The Bronx

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-02-28
Est. Completion 2027-03
Phase NA

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT06860425

The ClinicalTrials.gov registry entry for NCT06860425 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 238-participant average among 8 other Cancer Patients trials with a reported enrollment target (79% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cancer Patients appearing as the primary indexed condition, and to 1 intervention - of which RestoreMe is the first listed.

NCT06860425 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06860425 about?

NCT06860425 is a clinical study titled "Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity". The overarching purpose of this study is to assess whether patients will use the app throughout treatment on a regular basis, as the ultimate goal is to provide an educational platform that can impact patient behaviors and understanding towards health.

What is the current status of trial NCT06860425?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2023-02-28. Estimated completion is 2027-03.

What conditions does trial NCT06860425 study?

This clinical trial studies the following conditions: Cancer Patients, Mobile Applications.

What interventions are being tested in trial NCT06860425?

The interventions under investigation include: RestoreMe (OTHER).

Who is sponsoring clinical trial NCT06860425?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06860425 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Patients

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.